Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07484204
Recruiting
Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia
Phase 1 · India · 4 sites
Registry update: 16 Sept 2026
NCT07738107
Recruiting
ATR 1072 in Participants With PRKAG2 Syndrome
Phase 1/2 · United States · 1 site
Registry update: 18 Sept 2026
NCT07661940
Recruiting
Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine
Phase 2 · Germany · 1 site
Registry update: 24 Sept 2026
2024-511410-20-01
Recruiting
A Study to Learn How Different Manufactured Products of the Study Medicine Called Osivelotor (PF-07940367) Taste and Are Taken Up Into the Blood When Mixed With Soft Foods or Liquids Given on an Empty Stomach or Given With Food or an Acid Reducing Agent in Healthy Adults
Phase 1 · Belgium · 1 site
Registry update: 7 Sept 2026
NCT07800104
Recruiting
Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic Dermatitis
Phase 1 · China · 1 site
Registry update: 2 Oct 2026
NCT07799974
Recruiting
Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational Study
Not applicable · Belgium · 1 site
Registry update: 17 Sept 2026
NCT06615973
Recruiting
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
Not applicable · United States · 1 site
Registry update: 29 Sept 2026
NCT07855302
Recruiting
CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus
Phase 1 · South Korea · 1 site
Registry update: 2 Oct 2026
NCT07738263
Recruiting
Body-Based and Mind-Based Regulation in Overweight and Obese Women
Not applicable · 1 site
Registry update: 4 Nov 2026
NCT07675733
Recruiting
A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and Feasibility
Not applicable · United Kingdom · 1 site
Registry update: 28 Oct 2026
NCT07486024
Recruiting
Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)
Phase 3 · France · 5 sites
Registry update: 16 Sept 2026
NCT07780656
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Phase 3 · United States · 8 sites
Registry update: 5 Nov 2026
NCT07893002
Recruiting
A Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent Study
Not applicable · India · 1 site
Registry update: 3 Nov 2026
NCT07650448
Recruiting
WATER IV PCa (AS Sub-study)
Not applicable · Hong Kong, United States · 28 sites
Registry update: 6 Nov 2026
NCT07811193
Recruiting
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Phase 2 · Argentina, Belgium, Brazil, Switzerland, China, Germany, Spain, France, United Kingdom, Greece, Hong Kong, Italy, South Korea, Mexico, Malaysia, Netherlands, Poland, Portugal, Singapore, Taiwan, United States · 122 sites
Registry update: 21 Oct 2026
NCT07854899
Recruiting
Natural History Study of Advanced RCD
Not applicable · Belgium, France, Ireland · 3 sites
Registry update: 8 Oct 2026
NCT07439484
Recruiting
Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial
Not applicable · United States · 1 site
Registry update: 5 Nov 2026
NCT06804655
Recruiting
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Phase 2 · Switzerland · 3 sites
Registry update: 21 Sept 2026
2026-525673-39-00
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
Phase 2 · Bulgaria, Czechia, Germany, Spain, Hungary, Poland · 42 sites
Registry update: 28 Oct 2026
NCT07803744
Recruiting
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Phase 1 · United States · 1 site
Registry update: 23 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.